The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) Philippines COVID-19 Emergency Response Project (P173877) EAST ASIA AND PACIFIC | Philippines | Health, Nutrition & Population Global Practice | IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 6 | ARCHIVED on 02-Feb-2023 | ISR54323 | Implementing Agencies: Department of Health, Republic of the Philippines Key Dates Key Project Dates Bank Approval Date: 22-Apr-2020 Effectiveness Date: 06-May-2020 Planned Mid Term Review Date: 09-May-2022 Actual Mid-Term Review Date: 03-Jun-2022 Original Closing Date: 29-Dec-2023 Revised Closing Date: 29-Dec-2023 pdoTable Project Development Objectives Project Development Objective (from Project Appraisal Document) To strengthen the Philippines' capacity to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness Has the Project Development Objective been changed since Board Approval of the Project Objective? No Components Table Name Strengthening Emergency COVID-19 Health Care Response:(Cost $881.00 M) Strengthening Laboratory Capacity at National and Sub-National Level to Support Emerging Infectious Diseases (EIDs) Prevention, Preparedness, and Response:(Cost $11.50 M) Implementation Management and Monitoring and Evaluation:(Cost $7.50 M) Contingent Emergency Response Component (CERC) Overall Ratings Name Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Satisfactory Satisfactory Overall Risk Rating Moderate Substantial Implementation Status and Key Decisions This implementation and results report reflects the implementation progress of the Philippines COVID-19 Emergency Response Project (PCERP) from July to November 2022, as well as findings of the implementation support mission conducted from November 21 to December 2, 2022. The progress towards achievement of project development objectives (PDO) remains satisfactory. The project has continued moving toward its development objectives, i.e., to strengthen the Philippines' capacity to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. The achievement of PDO indicators is largely on track. 2/2/2023 Page 1 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) The implementation progress remains satisfactory. The overall implementation has been on track. Most actions agreed during the mid-term review (MTR) have been completed, and the rest are in progress. MPA Program Development Objective MPA PDO Table The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness MPA Table Multiphase Programmatic Approach (MPA) Status MPA Table Body Sustained efforts continue to be made to advance the implementation of the 87 MPA operations. As of December 19, 2022, 88 MPA-projects had been approved with a total commitment of US$4.3 billion. One operation (Guatemala) was cancelled in mid-September 2021, at the request of the Government. Six parent projects were restructured to include vaccine-related procurement. Twenty-three (23) operations are being implemented in Fragile and Conflict-affected situations. Total disbursements as of December 19, 2022, amount to US$3.76 billion or 87% of overall commitments. This amount does not include disbursements under MPA-V operations which are reported together with AF-V operations. Loans and Credits denominated in SDRs and Euros are being affected because of fluctuations between the SDRs and Euros against the US dollar. At this late stage of implementation, several operations are processing refunds to their special accounts and therefore, total disbursements are affected. Four country operations closed by the end of FY22. Eight operations are closing by the end of the CY. Sixty-nine (69) operations or 79 percent of projects approved have reached 70-100 percent disbursement (reasons for >100% disbursements relate to fluctuations between the Euro and the SDR against the US$). Out of the 69 operations, 53 operations or 77 percent have disbursed over 90+% of commitments. Out of the 69 operations, 34 operations or 49 percent are fully disbursed and four operations have disbursed 99 percent of commitment. There are nine operations with disbursements of 50 percent or less. Out of these nine operations, one has not disbursed (AFW), and two have disbursed 30 percent or less. The projects are benefitting around 3.7 billion people or 50% of the global population. If countries that have AF-V operations are counted, the projects are benefitting 4.1 billion of 51 percent of the global population. This is because some countries that don’t have a parent project have AF operations. Of the 87 active projects: (i) 33 are in Africa – 12 in AFE and 21 in AFW; (ii) 12 in East Asia; (iii) 14 in Europe and Central Asia; (iv) 11 in Latin America and the Caribbean; (v) 8 in Middle East and North Africa; and (vi) 9 in South Asia. Eighty-six (86) or 99% of projects approved are disbursing. MNA has the highest percentage of disbursements, followed by ECA, SRA, EAP LAC, AFE, and AFW. Retroactive Financing represents 19 percent of commitments. SRA has the highest percentage of RF at 35 percent. Streamlined procedures, delegated approvals, coupled with flexible project design and intensified efforts across the Bank have contributed to the progress. Implementation is being guided by Bank teams working in parallel with other health related projects, including Additional Financing operations supporting vaccine procurement and deployment efforts. Notwithstanding challenges of implementation, the MPA is on track to achieve its PrDO, which is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. The Additional Financing (MPA AF-V) to the COVID-19 Strategic Preparedness and Response Program utilizing the Multiphase Programmatic Approach (Global COVID-19 MPA) was approved by the Board on October 13, 2021. The AF-V was approved with an envelope of US$12 billion ($6 billion from IDA and $6 billion from IBRD) in financing. On June 30, 2021, President Malpass announced the expansion of financing available for COVID-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion. The AF-V is expected to enable vaccination for up to 750 million people, with potential surge capacity for an additional 250 million people in the poorest countries while scaling support to strengthen immunization delivery, with design flexibility at the country level. The AF-V is a scale-up of planned vaccination activities anticipated and supported under the Global COVID-19 MPA and a key contribution to the WBG’s overall COVID-19 2/2/2023 Page 2 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) response. As of November 2022, 632 million doses had been procured with Bank financing out of which 484 million doses have been delivered. As of December 19, 2022, the Bank has approved 116 operations (including MPA-V operations) to support vaccine procurement and rollout in 80 countries amounting to $10.1 billion. The 116 operations approved, include 6 operations that involved restructuring of parent projects (Bhutan, Cameroon, North Macedonia, Philippines, and Pakistan) and in the case of Lebanon, restructuring of the Health Resilience Project. Of the 116 approved operations: (i) 64 are in Africa – 29 in AFE and 35 in AFW; (ii) 10 in East Asia and the Pacific; (iii) 11 in Europe and Central Asia; (iv) 13 in Latin America and the Caribbean; (v) 9 in Middle East and North Africa; and (vi) 9 in South Asia. Seventy-two (72) projects or 62 percent of total operations approved are disbursing. Twenty-three operations are in Fragile and Conflict-affected countries. IDA represents 41 percent and IBRD 59 percent of disbursements. Total disbursements under these projects as of December 19, 2022, amount to US$5.45 billion or 54 percent of overall commitments. Disbursements under MPA-V operations are included in this total while disbursements under the six restructured projects are counted under parent projects. Thirty (30) or 26 percent of AF-V and MPA-V operations have disbursed 70 percent or more of their commitments. Out of the 30, twelve operations or 40 percent have disbursed 90 percent. Out of the twelve, three operations are fully disbursed and four have disbursed 98 percent of commitments. Retroactive Financing (RF) represents 38 percent of overall commitments. High RF has been authorized under different operations - Ukraine (100%), Panama and Turkey (90%), Argentina and Guyana (80%), and Belize, Iraq and Sri Lanka (70%). One hundred and nine (109) loan/financing agreements or 94 percent of projects approved have been signed. One hundred (100) loan/financing agreements or 86 percent of projects approved have become effective. As with the MPA operations, streamlined procedures, delegated approval, coupled with flexible project design, and intensified efforts across the Bank have contributed to the rapid design, processing, and implementation of the operations. Risks Systematic Operations Risk-rating Tool Risk Category Rating at Approval Previous Rating Current Rating Political and Governance Substantial Substantial Substantial Macroeconomic Substantial Moderate Moderate Sector Strategies and Policies Substantial Substantial Substantial Technical Design of Project or Program Moderate Substantial Substantial Institutional Capacity for Implementation and Substantial Substantial Substantial Sustainability Fiduciary Substantial Substantial Substantial Environment and Social Substantial Substantial Substantial Stakeholders Moderate Substantial Substantial Other Substantial Moderate Moderate Overall Substantial Moderate Substantial Results PDO Indicators by Objectives / Outcomes 2/2/2023 Page 3 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) To strengthen Philippines' capacity to prevent, detect and respond to the threat posed by COVID-19 IN01229670 ►Percentage of hospitals with personal protective equipment and infection control products and supplies according to DOH requirements, without stock-outs in preceding one month (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 55.00 84.00 91.00 90.00 Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229751 ►Percentage of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents, without stock-outs in preceding one month (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 20.00 83.00 83.00 90.00 Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229752 ►Number of acute healthcare facilities with isolation capacity according to DOH-established standards (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 30.00 52.00 81.00 60.00 Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229753 ►Percentage of project-targeted health workers that received primary doses of COVID-19 vaccine (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 94.88 97.00 80.00 Date 13-Jan-2021 18-May-2022 30-Nov-2022 29-Dec-2023 IN01229754 ►Percentage of project-financed vaccines administered and reported in line with the DOH’s protocol (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 57.76 79.70 95.00 Date 25-Oct-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 Intermediate Results Indicators by Components Strengthening Emergency COVID-19 Health Care Response IN01229757 ►Standard design for hospital isolation and treatment centers to manage Severe Acute Respiratory Infections (SARI) patients is finalized (Yes/No, Custom) 2/2/2023 Page 4 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229760 ►Number of ventilators provided to hospitals (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 500.00 500.00 300.00 Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229763 ►Number of health staff trained in infection prevention and control per DOH-approved protocols (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 18,785.00 18,785.00 15,000.00 Date 03-Apr-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229764 ►Percentage of hospitals designated as vaccination sites in project areas having adequate and functioning cold chain equipment (CCE) maintaining temperature required for the COVID-19 vaccine assigned (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 100.00 100.00 100.00 Date 13-Jan-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229765 ►Percentage of project-procured vaccinated population and parents/guardians of individuals aged 12-17 who rated as satisfactory the COVID-19 vaccination services received (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 98.60 98.60 80.00 Date 13-Jan-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229766 ►Percentage of serious AEFI cases who have received treatment according to DOH’s protocol, disaggregated by adults and individuals aged 12-17 (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 72.40 75.00 80.00 Date 13-Jan-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229767 ►National COVID-19 vaccination tools developed (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target 2/2/2023 Page 5 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) Value No Yes Yes Yes Date 18-Jan-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229768 ►Eligibility for vaccination criteria include barangay health workers (BHWs) among priority group (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 02-Feb-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229769 ►Number of vaccine doses procured by the project (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 33,021,580.00 33,021,580.00 38,000,000.00 Date 11-Mar-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 Comments: IN01229770 ►Percentage of project-targeted individuals aged 12-17 who received primary dose vaccines as per the government plan and the Bank’s VAC, disaggregated by sex (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 87.57 78.74 60.00 Date 25-Oct-2021 18-May-2022 30-Nov-2022 29-Dec-2023 IN01229771 ►Percentage of project-targeted vulnerable population that received additional/booster doses of COVID-19 vaccine as per the government plan, disaggregated by sex and age (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 15.17 36.00 70.00 Date 25-Oct-2021 18-May-2022 30-Nov-2022 29-Dec-2023 IN01229772 ►Percentage of project-targeted health workers that received booster doses as per the government plan, disaggregated by sex and age (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 51.04 65.00 70.00 Date 25-Oct-2021 18-May-2022 30-Nov-2022 29-Dec-2023 IN01229773 ►Percentage of the population willing to get vaccinated, disaggregated by sex (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target 2/2/2023 Page 6 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) Value 23.00 80.00 80.00 70.00 Date 22-Nov-2021 29-Apr-2022 30-Nov-2022 29-Dec-2023 Strengthening Laboratory Capacity at National and Sub-National Level IN01229755 ►Daily capacity of a designated national laboratory (RITM) in conducting COVID-19 diagnostic tests (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 300.00 23.00 25.00 1,200.00 Date 31-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229758 ►Daily capacity of a designated sub-national laboratory (Davao) in conducting COVID-19 diagnostic tests (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 20.00 249.00 288.00 500.00 Date 30-Mar-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229761 ►Daily capacity of a designated sub-national laboratory (Cebu) in conducting COVID-19 diagnostic tests (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 20.00 427.00 409.00 500.00 Date 03-Apr-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 Implementation Management and Monitoring and Evaluation IN01229756 ►M&E system established to monitor project activities (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 03-Apr-2020 29-Apr-2022 30-Nov-2022 30-Jun-2020 IN01229759 ►Functional asset management system is in place, independently reviewed on 6-monthly basis (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No Yes Yes Yes Date 03-Apr-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 IN01229762 2/2/2023 Page 7 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) ►Percentage of grievances resolved to the satisfaction of the complainant within timeframe specified in the GRM for stakeholders (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 100.00 100.00 80.00 Date 06-Nov-2020 29-Apr-2022 30-Nov-2022 29-Dec-2023 Performance-Based Conditions Data on Financial Performance Disbursements (by loan) Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P173877 IBRD-91050 Effective USD 100.00 100.00 0.00 84.20 15.80 84% P173877 IBRD-92200 Effective USD 500.00 500.00 0.00 455.79 44.21 91% P173877 IBRD-93280 Effective USD 300.00 300.00 0.00 0.00 300.00 0% Key Dates (by loan) Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date P173877 IBRD-91050 Effective 22-Apr-2020 28-Apr-2020 06-May-2020 29-Dec-2023 29-Dec-2023 P173877 IBRD-92200 Effective 11-Mar-2021 19-Mar-2021 31-Mar-2021 29-Dec-2023 29-Dec-2023 P173877 IBRD-93280 Effective 21-Dec-2021 29-Dec-2021 21-Mar-2022 29-Dec-2023 29-Dec-2023 Cumulative Disbursements 2/2/2023 Page 8 of 9 The World Bank Implementation Status & Results Report Philippines COVID-19 Emergency Response Project (P173877) Restructuring History Level 2 Approved on 29-Dec-2020 ,Level 2 Approved on 10-Sep-2021 Related Project(s) P175953-Philippines COVID-19 Emergency Response Project Additional Financing ,P177884-Philippines COVID-19 Emergency Response Project - Additional Financing 2 2/2/2023 Page 9 of 9